D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$327M |
| 2 |
Netflix
NFLX
|
+$275M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$219M |
| 4 |
Citigroup
C
|
+$211M |
| 5 |
Merck
MRK
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$558M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$259M |
| 3 |
Meta Platforms (Facebook)
META
|
+$252M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$252M |
| 5 |
IBM
IBM
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.41% |
| 2 | Technology | 6.9% |
| 3 | Consumer Discretionary | 6.89% |
| 4 | Communication Services | 6.41% |
| 5 | Healthcare | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
PUT
CNO Financial Group
CNO
$4.94B
| $1.46M | ﹤0.01% |
+82,600
| New | +$1.32M |
|
2802
Unitil
UTL
$989M
| $1.46M | ﹤0.01% |
47,927
+4,585
| +11% | +$138K |
|
2803
Community Health Systems
CYH
$382M
| $1.46M | ﹤0.01% |
44,935
-77,493
| -63% | -$2.66M |
|
|
DSPG
2804
DELISTED
DSP Group Inc
DSPG
| $1.46M | ﹤0.01% |
150,156
+68,869
| +85% | +$561K |
|
|
GSIG
2805
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $1.46M | ﹤0.01% |
129,734
+19,229
| +17% | +$200K |
|
|
NE
2806
DELISTED
Noble Corporation
NE
| $1.46M | ﹤0.01% |
44,471
-651,057
| -94% | -$21.6M |
|
|
MEAS
2807
CALL
DELISTED
MEASUREMENT SPECIALTIES INC
MEAS
| $1.46M | ﹤0.01% |
24,000
+4,000
| +20% | +$221K |
|
2808
Omeros
OMER
$845M
| $1.46M | ﹤0.01% |
128,992
+116,800
| +958% | +$1.13M |
|
2809
CALL
YPF
YPF
$19.7B
| $1.45M | ﹤0.01% |
+44,100
| New | +$1.13M |
|
2810
Black Hills Corp
BKH
$5.55B
| $1.45M | ﹤0.01% |
27,645
+18,745
| +211% | +$951K |
|
2811
Western Alliance Bancorporation
WAL
$8.81B
| $1.45M | ﹤0.01% |
60,830
-43,963
| -42% | -$959K |
|
2812
PUT
Cameco
CCJ
$36.8B
| $1.45M | ﹤0.01% |
69,800
+20,000
| +40% | +$388K |
|
2813
Darling Ingredients
DAR
$9.32B
| $1.45M | ﹤0.01% |
69,465
+935
| +1% | +$20K |
|
2814
Greenlight Captial
GLRE
$579M
| $1.45M | ﹤0.01% |
43,013
+17,351
| +68% | +$543K |
|
|
ZLTQ
2815
CALL
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $1.45M | ﹤0.01% |
+76,700
| New | +$1.1M |
|
|
NEWP
2816
DELISTED
NEWPORT CORP
NEWP
| $1.45M | ﹤0.01% |
80,025
+47,319
| +145% | +$775K |
|
2817
Stoneridge
SRI
$200M
| $1.44M | ﹤0.01% |
113,271
+30,469
| +37% | +$378K |
|
2818
Choice Hotels
CHH
$5.26B
| $1.44M | ﹤0.01% |
+29,273
| New | +$1.33M |
|
2819
Sturm, Ruger & Co
RGR
$603M
| $1.44M | ﹤0.01% |
+19,678
| New | +$1.39M |
|
|
KOG
2820
DELISTED
KODIAK OIL & GAS CORP
KOG
| $1.44M | ﹤0.01% |
128,119
-201,917
| -61% | -$2.42M |
|
|
CBST
2821
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $1.43M | ﹤0.01% |
20,801
-177,659
| -90% | -$11.5M |
|
2822
CALL
Popular Inc
BPOP
$11B
| $1.43M | ﹤0.01% |
49,700
| – | – |
|
|
ACW
2823
DELISTED
Accuride Corp
ACW
| $1.43M | ﹤0.01% |
382,542
+7,009
| +2% | +$27.7K |
|
2824
Cogent Communications
CCOI
$635M
| $1.43M | ﹤0.01% |
35,287
-117,542
| -77% | -$4.28M |
|
|
FOLD
2825
DELISTED
Amicus Therapeutics
FOLD
| $1.43M | ﹤0.01% |
607,048
+187,355
| +45% | +$411K |
|
Similar funds
D.E. Shaw & Co's Q4 2013 Portfolio in Review
As of Q4 2013, D.E. Shaw & Co held 4,972 positions worth $73.3B, up 17% from $62.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co deployed $3.59B of net new capital in Q4 2013, opening 721 new positions and adding to 1,786 existing holdings. Its largest new stake was Allegion: 2,233,249 shares worth $98.7M.
By sector, the portfolio is most concentrated in Financials at 7.4% of assets, up from 6.8% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $252M trimmed.
- D.E. Shaw & Co's largest Q4 2013 buy was Allegion: 2,233,249 shares worth $98.7M.
- D.E. Shaw & Co added most to Bank of America in Q4 2013, an estimated $327M increase.
- D.E. Shaw & Co's biggest Q4 2013 reduction was Meta Platforms (Facebook), cutting an estimated $252M.
- D.E. Shaw & Co fully exited DELL INC in Q4 2013, selling an estimated $558M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $73.3B portfolio in Q4 2013.
- D.E. Shaw & Co opened 721 new positions and closed 549 in Q4 2013.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $73.3B.
Based on D.E. Shaw & Co's 13F filing for Q4 2013, filed 14 Feb 2014.